Romania’s largest private healthcare services provider, MedLife, bought a new stake of 40 percent in Stem Cells Bank in Timisoara, one of the most modern and well equipped stem cells bank in south-eastern Europe, a press release informs.
“In 2015, we announced the entrance into a new business segment with the beginning of the acquisition process of the majority stake in Stem Cells Bank, and the decision to buy another stake of 40 percent is a natural step in the development of our business. With the integration of this service we were able to provide complete solutions for mother and child in our own regime, currently having over 24,000 births in total in our three maternity hospitals,” Mihai Marcu, MedLife President and CEO stated.
Stem Cells Bank was inaugurated in 2010 in Timisoara and is the stem cells bank that possesses the most modern processing system in Romania, based on the Biosafe Sepax 2 technology, and at the same time, the only private stem cells bank in the Balkan region that uses this technology, through which stem cells processing and isolation is fully automated, thus eliminating all risks of contamination in the laboratory.
In addition, MedLife also takes over another 3 percent in the Genesys Medical Clinic group in Arad, one of the largest private healthcare operators in the western Romania, with the company currently owning a stake of 58 percent.
MedLife Genesys Arad includes a large hospital, a maternity hospital, an outpatient department and a laboratory. Over the years, MedLife Genesys has developed several medical centres in the cities of Deva, Hunedoara, Petrosani, Drobeta Turnu Severin and Targu-Jiu, while the radiology and medical imaging centre was inaugurated last year, being the only centre in Arad that has digital radiography equipment.
From 2010 until now, MedLife has completed 15 acquisitions.